- LifeStance Health Group press release ( NASDAQ: LFST ): Q2 GAAP EPS of -$0.19 misses by $0.05 .
- Revenue of $209.5M (+30.5% Y/Y) misses by $2.97M .
- Revenue of $209.5 million increased $49.0 million or 31% compared to revenue of $160.5 million
- Total clinicians of 5,226 up 31%, a net increase of 237 in the second quarter
- Net loss of $68.7 million compared to net loss of $70.0 million, primarily driven by stock-based compensation expense of $57.5 million
- Adjusted EBITDA of positive $14.6 million compared to Adjusted EBITDA of positive $14.5 million
- Expecting full year 2022 revenue and Center Margin toward the bottom end of the previously guided ranges of $865 million to $885 million and $240 million to $255 million, respectively, due to refined clinician seasonality assumptions; reaffirming Adjusted EBITDA guidance of $63 million to $67 million
For further details see:
LifeStance Health Group GAAP EPS of -$0.19 misses by $0.05, revenue of $209.5M misses by $2.97M